openPR Logo
Press release

Acute Myeloid Leukemia (AML) Biomarker Testing Market to witness consistent growth in next 5 years

09-12-2022 02:47 PM CET | Health & Medicine

Press release from: Persistence Market Research

Acute Myeloid Leukemia (AML) Biomarker Testing Market

Artificial Intelligence is the future of the healthcare industry. This could be attributed to improvements in diagnostic precision as there would be automatic assistance regarding clinical operation, workforce, and quantitative imaging. The Acute Myeloid Leukemia Biomarker Testing Market report by Persistence Market Research emphasizes on the inflow of artificial intelligence therein and also the medications (pharmaceuticals) to be rendered. Precise diagnostics leads to precise rendition of drugs.

Acute myeloid leukemia (AML) is cancer that initiates inside bone marrow and affects the whole blood. Acute myeloid leukemia (AML) is not just a single disease but a group of leukemias that develops in the myeloid cell line in the bone marrow. Acute myeloid leukemia (AML) occurs due to overproduction of immature white blood cells often known as myeloblast or leukemic blast. Cancer develops from cells that would normally turn into white blood cells.

Strategizing the moves for the next decade? See through sample of Acute Myeloid Leukemia Biomarker Testing market report! https://www.persistencemarketresearch.com/samples/26236

The myeloblast gathers in the bone marrow, preventing it from making normal blood cells. This results in disturbing the growth of other blood cells in the body leading to weaker immunity. The pathophysiology of acute myeloid leukemia (AML) is just beginning to be understood at the molecular level, and currently, biomarkers markers are the most important for risk stratification and treatment of acute myeloid leukemia (AML) patients.

Market Segmentation:
By Biomarker Type
• Genetic Acute Myeloid Leukemia (AML) Biomarker
o FLT3
o NPM1
o TP53
o MU-AML
o others
• Epigenetic Acute Myeloid Leukemia (AML) Biomarker
o IDH1/2
o TET
o DNMT3A
• Proteomic Acute Myeloid Leukemia (AML) Biomarker
o HNRH1
o CALR
o FIBA
o HSP

By End User
• Hospitals
• Cancer diagnostic Centers
• Research Institutes
• Others

Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

How about knowing the geographical spread of the Acute Myeloid Leukemia Biomarker Testing market? Glance through the "Table of Content" of the Acute Myeloid Leukemia Biomarker Testing market report! https://www.persistencemarketresearch.com/toc/26236

On the basis of biomarker type, genetic acute myeloid leukemia (AML) biomarker is expected to registers the largest revenue share in acute myeloid leukemia (AML) biomarker testing market as many leading manufacturing companies have launched genetic biomarker testing products in the market. Whereas, among end users, cancer diagnostic centers is anticipated to register the highest growth rate over the forecast period.

Geographically, global acute myeloid leukemia (AML) biomarker testing market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. North America is projected to be a major market for acute myeloid leukemia (AML) biomarker testing market owing to rise in prevalence of cancer. It was reported by the American Cancer Society (ACS), that in 2017, it is estimated that 1,688,780 new cancer cases are diagnosed and 600,920 cancer deaths in the U.S. alone.

Europe is expected to hold second largest share in global acute myeloid leukemia (AML) biomarker testing market due to due to increasing research and development activities to diagnose and treat acute myeloid leukemia (AML). APAC acute myeloid leukemia (AML) biomarker testing market is expected to be fastest growing market due to increase in demand for the non-invasive techniques in diagnosis and prevention of cancer, the high prevalence of cancer conditions in the region.

Want to know which technology/product drives the major portion of revenue to the Acute Myeloid Leukemia Biomarker Testing market? Prebook the Acute Myeloid Leukemia Biomarker Testing market report to get through the details! https://www.persistencemarketresearch.com/checkout/26236

Some of the players identified in the global acute myeloid leukemia (AML) biomarker testing market are Abbott Laboratories, Novartis AG, Thermo Fisher Scientific, Cancer Genetics Inc., Sysmex Corporation, Epigenomics AG, bioMérieux SA, Skyline DX B.V., etc. among others.

Contact Us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com

About Us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Acute Myeloid Leukemia (AML) Biomarker Testing Market to witness consistent growth in next 5 years here

News-ID: 2731492 • Views:

More Releases from Persistence Market Research

Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Persistence Market Research
Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers …
➤ Overview of the Market The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance to
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by Sustainability and Supply Chain Efficiency
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S …
➤ Overview of the Market The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million in
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Growth - Persistence Market Research
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr …
➤Overview of the Market The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. According
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Healthcare Demand
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health …
➤Overview of the Market The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gained

All 5 Releases


More Releases for AML

Top Trends Transforming the Hemato Oncology Testing Market Landscape in 2025: Ne …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Hemato Oncology Testing Industry Market Size Be by 2025? There has been a swift expansion in the hemato oncology testing market in the past few years. The market, which was valued at $3.5 billion in 2024, is predicted to surge to $3.96 billion in 2025, reflecting
AML BitCoin Founder Asks President Trump to release their AML BITCOIN Classified …
The DOJ and the FBI should practice tough love while also providing financial incentives for government employees that uphold the constitution and obey the law. AG Bondi and Director Patel should ask President Trump for access to some of the billions of dollars that DOGE has saved us and utilize it for pay raises. Their employees need to be taken care of financially, or their hardships will make them the
Anti-Money Laundering (AML) Software Market Is Booming So Rapidly with Thomson R …
The Latest published market study on Global Anti-Money Laundering (AML) Software Market provides an overview of the current market dynamics in the Anti-Money Laundering (AML) Software space, as well as what our survey respondents all outsourcing decision-makers predict the market will look like in 2032. The study breaks the market by revenue and volume (wherever applicable) and price history to estimate the size and trend analysis and identify gaps and
Global Anti Money Laundering (AML) Software Market Size, Share and Forecast By K …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the Market Research Intellect, the global Anti Money Laundering (AML) Software market is projected to grow at a robust compound annual growth rate (CAGR) of 14.78% from 2024 to 2031. Starting with a valuation of 7.83 Billion in 2024, the market is expected to reach approximately 17.9 Billion by 2031, driven by factors such as Anti Money Laundering (AML) Software and Anti Money Laundering (AML)
What is AML Verification? A Detailed Guide
With the rise of cryptocurrencies and the increasing adoption of digital assets, regulatory frameworks have become a critical component for ensuring that the cryptocurrency space remains secure and compliant. One of the most important elements in this regulatory framework is AML verification, which stands for Anti-Money Laundering. Image: https://revbit.net/wp-content/uploads/2024/10/aml-in-crypto-3-1024x640.png What is AML Verification? AML (Anti-Money Laundering) verification [https://revbit.net/] refers to a set of procedures and regulations designed to prevent illegal activities such as
IventiumPro.io Adheres to Strict KYC and AML Regulations
London, United Kingdom - IventiumPro.io [http://iventiumpro.io], a company that provides a reliable financial services, is committed to maintaining high standards of regulatory compliance. The company follows Know Your Customer (KYC) and Anti-Money Laundering (AML) regulations to ensure the integrity and security of its operations. This adherence reflects a strong dedication to preventing illegal activities and protecting the financial system. KYC regulations are designed to verify the identity of clients. IventiumPro.io collects